Use of antiepileptic drugs in non-epileptic disorders;Uso de los fármacos antiepilépticos en trastomos no epilépticos

Revista de Neurologia

Volumn 33, Issue 3, 2001, Pages 241-249

  Caviedes, B E ^a   Herranz, J L ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Antiepileptic drugs; Bipolar disorders; Bulimia; Migraine; Neuropathic pain; Neuroprotection

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; BACLOFEN; CAPSAICIN; CARBAMAZEPINE; CLONIDINE; GABAPENTIN; LAMOTRIGINE; LIDOCAINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

BULIMIA; CONFERENCE PAPER; DRUG EFFECT; DRUG INDICATION; DRUG USE; MANIC DEPRESSIVE PSYCHOSIS; MIGRAINE; NEUROPROTECTION; PAIN; PROPHYLAXIS; TRIGEMINUS NEURALGIA;

EID: 17944403559     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3303.2001170     Document Type: Conference Paper

References (99)

1. Sodium channels and the molecular pathophysiology of pain
2. Synaptic transmission and plasticity in the superficial dorsal horn
3. Synaptic mechanisms of hyperalgesia
4. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons
5. Spine pain mechanisms
6. Pain mechanisms and management: A central perspective
7. Neuropathic pain: Aetiology, symptoms, mechanisms, and management
8. Muscle but no cutaneous C-afferent input produces increases in the excitability of the flexion reflex in the rat
9. Protein-kinase subtypes involved in injury-induced nociception
10. Paraesthesiae from ectopic impulse generation in human sensory nerves
11. Datos actuales sobre gabapentina
12. Gabapentin actions in ligandand voltage-gated responses in cultured rodent neurons
13. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model iff the rat
14. Gabapentin in pain management
15. Gabapentin in the management of neuropathic pain
16. Gabapentin adjunctive therapy in neuropathic pain states
17. Gabapentin for painful diabetic neuropathy
18. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomised controlled trial
19. Acute herpetic neuralgia in the head and neck: Response to gabapentin in five cases
20. Gabapentin for the treatment of postherpetic neuralgia: A randomised controlled trial
21. Pain in Guillain-Barré syndrome
22. Efecto de gabapentina en la alodinia bucofacial. Correlación experimental con neuralgia trigeminal
23. Gabapentin for idiopathic trigeminal neuralgia: Report of two cases
24. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients
25. Erythromelalgia pain managed with gabapentin
26. Respuesta clínica a la gabapentina en la neuralgia del glosofaríngeo
27. Papel de la gabapentina en el manejo del dolor asociado a la enfermedad de paget
28. Gabapentin in the treatment of painful diabetic neuropathy. A placebo controlled double-blind, crossover trial
29. Gabapentin vs amitriptiline in painful diabetic neuropathy: An open-label pilot study
30. Randomized double-blind study comparing the efficacy of gabapentin with amitriptiline on diabetic peripheral neuropathic pain
31. The novel anticonvulsant topiramate is antiallodynic in a rat model of neuropathic pain
32. Topiramate: A novel approach to neuropathic pain syndromes
33. Trigeminal neuralgia: Its treatment with a new anticonvulsant drug (G32883)
34. Treatment of trigeminal neuralgia using the immunostilbine derivate G-32883
35. The treatment of trigeminal neuralgia: Preliminary experience with Tegretol
36. Clinical trial of carbamazepine in trigeminal neuralgia
37. Carbamazepine inhibits spontaneous activity in experimental neuromas
38. Phenytoin suppresses spontaneous ectopic discharge in rat sciatic nerve neuromas
39. Preventive treatment of migraine, an overview
40. Nuevas perspectivas en el tratamiento de la migraña
41. Tratamiento profiláctico con gabapentina de la cefalea crónica diaria resistente a otros fármacos
42. Gabapentin in migraine drug resistant
43. Gabapentin in the prophylaxis of migraine: A double-blind randomised placebo-controlled study
44. Efficacy and safety of gabapentin (Neurontin) in migraine prophylaxis
45. Efficacy and safety of gabapentin in prophylaxis migraine headache. A pilot study
46. Treatment of migraine with antiepileptic drugs
47. Topiramate in the treatment of chronic migraine and other headaches
48. Efficacy of topiramate in the prophylactic treatment of intractable migraine: A retrospective chart analysis
49. A double-blind randomized, placebo-controlled study of topiramate in the prophylactic treatment of migraine with and without aura
50. Prophylactic treatment of episodic migraine with topiramate: A double-blind, placebo-controlled trial in 30 patients
51. Topiramate-responsive cluster headache
52. An open-label study of topiramate for migraine prevention
53. Efficacy of topiramate in prophylactic treatment of migraines in patients refractory to preventive intervention: A retrospective chart review in a tertiary clinic
54. Efficacy of topiramate in prophylaxis of frequent severe migraines or chronic daily headaches: Experience with 68 patients over 18 months
55. Use of topiramate as prophylactic treatment in migraine: Results of a pilot study
56. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura
57. Lamotrigine in the prophylactic treatment of migraine aura. A pilot study
58. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: An open pilot study
59. Treatment of acute mania with gabapentin
60. Gabapentin in treatment of bipolar and schizoaffective disorders
61. Gabapentin in the treatment of bipolar disorder
62. Gabapentin in bipolar disorder
63. A pilot trial of adjunctive gabapentin in treatment of bipolar disorder
64. Acute treatment of bipolar depression with gabapentin
65. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania
66. Gabapentin treatment of mood disorders: A preliminary study
67. An open label study of gabapentin in the treatment of acute mania
68. Gabapentin in the treatment of adolescent mania: A case report
69. Utilización del topiramato como nuevo estabilizador del humor
70. Low plasma GABA is a traitlike marker for bipolar illness
71. Topiramate increases cerebral GABA in healthy humans
72. Acetazolamide in bipolar affective disorders
73. Acetazolamide in the treatment of acute mania
74. Open-label adjunctive topiramate of bipolar disorders
75. Use of topiramate, a new antiepileptic as a mood stabilizer
76. Treatment of bipolar depression with topiramate
77. Estudio abierto sobre la efectividad y la seguridad del topiramato en el trastorno bipolar resistente
78. Third generation antiepileptic drugs in bipolar disorder
79. Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder
80. Use of lamotrigine in the treatment of bipolar disorder
81. Antidepressant effects of lamotrigine in rapid cycling bipolar disorder
82. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder
83. Lamotrigine treatment of refractory bipolar disorder
84. An open study of lamotrigine in refractory bipolar depression
85. A double-blind placebo controlled study of lamotrigine monotherapy in outpatients with bipolar I depression
86. A double-blind placebo-controlled study supporting the efficacy of lamotrigine in unipolar depression
87. Lamotrigine compared with lithium in mania: A double-blind randomised controlled trial
88. Effect of topiramate on body weight and body composition of Osborne-Mendel rats fed a high-fat diet: Alterations in hormones, neuropeptide, and uncoupling-protein mRNAs
89. The lateral Hypothalamus, a primary site mediating excitatory aminoacid-elicited eating
90. Influence of topiramate in the regulation of energy balance
91. Treatment of binge-eating disorder with topiramate: A clinical case series
92. Gabapentin: Long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders
93. Gabapentin as a potential treatment for anxiety disorders
94. A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias
95. Effectiveness of gabapentin for the treatment of behavioral disorders in dementia
96. Mechanisms of disease modification
97. Developmental mechanisms that generate precise patterns of neuronal connectivity
98. Neuroprotective properties of topiramate in a model of limbic status epilepticus